These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 26986226)

  • 1. Research and development of antibiotics: insights from patents and citation network.
    Zhang M; Kong X; Zheng J; Wan JB; Wang Y; Hu Y; Shao R
    Expert Opin Ther Pat; 2016 May; 26(5):617-27. PubMed ID: 26986226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metalloenzyme inhibitors for the treatment of Gram-negative bacterial infections: a patent review (2009-2012).
    Supuran CT; Carta F; Scozzafava A
    Expert Opin Ther Pat; 2013 Jul; 23(7):777-88. PubMed ID: 23458841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of antibiotic patents issued in China from 1992 to 2011.
    Xie H; Zhang H; Zhang S; He S
    Expert Opin Ther Pat; 2012 Oct; 22(10):1205-32. PubMed ID: 22957903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Research and development of anti-Alzheimer's drugs: an analysis based on technology flows measured by patent citations.
    Xu J; Kong X; Qiu L; Geng X; Hu Y; Wang Y
    Expert Opin Ther Pat; 2014 Jul; 24(7):791-800. PubMed ID: 24798577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in bacteriocin application as antimicrobials.
    Gillor O; Ghazaryan L
    Recent Pat Antiinfect Drug Discov; 2007 Jun; 2(2):115-22. PubMed ID: 18221167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statement.
    Chopra I; Schofield C; Everett M; O'Neill A; Miller K; Wilcox M; Frère JM; Dawson M; Czaplewski L; Urleb U; Courvalin P
    Lancet Infect Dis; 2008 Feb; 8(2):133-9. PubMed ID: 18222164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxazolidinone antimicrobials: a patent review (2012-2015).
    Phillips OA; Sharaf LH
    Expert Opin Ther Pat; 2016 May; 26(5):591-605. PubMed ID: 26998627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotics in the clinical pipeline in 2011.
    Butler MS; Cooper MA
    J Antibiot (Tokyo); 2011 Jun; 64(6):413-25. PubMed ID: 21587262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The rise of resistant gram-negative bacteria].
    Kuijper EJ; van Dissel JT
    Ned Tijdschr Geneeskd; 2010; 154(45):A2868. PubMed ID: 21118590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing Antibiotic Dosing Strategies for the Treatment of Gram-negative Infections in the Era of Resistance.
    Monogue ML; Kuti JL; Nicolau DP
    Expert Rev Clin Pharmacol; 2016; 9(3):459-76. PubMed ID: 26678036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of resistance in microorganisms by help of non-antibiotics.
    Kristiansen JE; Hendricks O; Delvin T; Butterworth TS; Aagaard L; Christensen JB; Flores VC; Keyzer H
    J Antimicrob Chemother; 2007 Jun; 59(6):1271-9. PubMed ID: 17403708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic resistance: how it arises, the current position and strategies for the future.
    Perry C; Hall C
    Nurs Times; 2009 Sep 15-21; 105(36):20-3. PubMed ID: 19835196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LpxC inhibitors: a patent review (2010-2016).
    Kalinin DV; Holl R
    Expert Opin Ther Pat; 2017 Nov; 27(11):1227-1250. PubMed ID: 28742403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Empiric antibiotics pending bronchoalveolar lavage data in patients without pneumonia significantly alters the flora, but not the resistance profile, if a subsequent pneumonia develops.
    Thakkar RK; Monaghan SF; Adams CA; Stephen A; Connolly MD; Gregg S; Cioffi WG; Heffernan DS
    J Surg Res; 2013 May; 181(2):323-8. PubMed ID: 22906560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel antibiotics: are we still in the pre-post-antibiotic era?
    Draenert R; Seybold U; Grützner E; Bogner JR
    Infection; 2015 Apr; 43(2):145-51. PubMed ID: 25701222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Calculated antibiotic therapy in gastroenterologic infections].
    Braun RW
    Praxis (Bern 1994); 2003 Aug; 92(33):1343-9. PubMed ID: 14502790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetic foot infections: Current treatment and delaying the 'post-antibiotic era'.
    Lipsky BA
    Diabetes Metab Res Rev; 2016 Jan; 32 Suppl 1():246-53. PubMed ID: 26452233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breaking barriers: expansion of the use of endolysins as novel antibacterials against Gram-negative bacteria.
    Briers Y; Lavigne R
    Future Microbiol; 2015; 10(3):377-90. PubMed ID: 25812461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Designing drugs that overcome antibacterial resistance: where do we stand and what should we do?
    Penchovsky R; Traykovska M
    Expert Opin Drug Discov; 2015 Jun; 10(6):631-50. PubMed ID: 25981754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic resistance: from Darwin to Lederberg to Keynes.
    Amábile-Cuevas CF
    Microb Drug Resist; 2013 Apr; 19(2):73-87. PubMed ID: 23046150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.